More SEC Filings
View Older Stories View Newer Stories-
Form 4 Waystar Holding Corp. For: Jun 16 Filed by: Riefberg Vivian E.
-
Form 4 Tarsus Pharmaceuticals, For: Jun 12 Filed by: YARNO WENDY L
-
Form 8-K Vimeo, Inc. For: Jun 16
-
Form 4 Tarsus Pharmaceuticals, For: Jun 12 Filed by: Morrison Scott W
-
Form 424B2 UBS AG
-
Form 144 CAVA GROUP, INC. Filed by: Xenohristos Theodoros
-
Form 144 Guidewire Software, Inc. Filed by: Rosenbaum Michael George
-
Form 4 T-Mobile US, Inc. For: Jun 12 Filed by: Nelson Mark Wolfe
-
Form 4 Waystar Holding Corp. For: Jun 16 Filed by: Roman Michael F
-
Form 424B2 UBS AG
-
Form 144 DOCUSIGN, INC. Filed by: Briggs Teresa
-
Form 144 BeOne Medicines Ltd. Filed by: Wang Lai
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form N-8F NB Private Markets Fund
-
Form 8-K AMPHENOL CORP /DE/ For: Jun 16
-
Form 144 Elastic N.V. Filed by: Kulkarni Ashutosh
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 4 AUTOMATIC DATA PROCESSIN For: Jun 12 Filed by: DeSilva Joseph
-
Form DEFA14A ALUMIS INC.
-
Form 424B2 UBS AG
-
Form 6-K GOLD FIELDS LTD For: Jun 16
-
Form 4 TEVA PHARMACEUTICAL INDU For: Jun 12 Filed by: Kalif Eliyahu Sharon
-
Form 4 Tarsus Pharmaceuticals, For: Jun 12 Filed by: LINK WILLIAM J PHD
-
Form 8-K PACS Group, Inc. For: Jun 12
-
Form 144 Evolus, Inc. Filed by: MOATAZEDI DAVID
-
Form 424B2 UBS AG
-
Form 8-K Stirling Hotels & Resort For: Jun 16
-
Form 8-K MICROSTRATEGY Inc For: Jun 12
-
Form 144 NICE Ltd. Filed by: Roy Awan
-
Form 8-K PARKERVISION INC For: Jun 10
-
Form 144 YELP INC Filed by: Schwarzbach David A
-
Form 424B2 UBS AG
-
Form 4 Mineralys Therapeutics, For: Jun 12 Filed by: Rodman David Malcom
-
Form 3 INDIA FUND, INC. For: Jun 10 Filed by: Tahilramani Rita
-
Form 424B2 UBS AG
-
Form 144 POWELL INDUSTRIES INC Filed by: COPE BRETT ALAN
-
Form 424B2 UBS AG
-
Form DEF 14A LIBERTY ALL STAR EQUITY For: Aug 19
-
Form 144 YELP INC Filed by: Jedda Dan
-
Form 424B2 UBS AG
-
Form D Sunridge Equity SPV LLC
-
Form 4 Waystar Holding Corp. For: Jun 16 Filed by: DeMichiei Robert
-
Form C-AR IdentifySensors Biologic For: Dec 31
-
Form 144 DEXCOM INC Filed by: FOLETTA MARK G
-
Form 20-F TAL Education Group For: Feb 28
-
Form D Welon Trust, Inc.
-
Form 6-K Alibaba Group Holding For: Jun 16
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG

